Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 8.

Eckert, C; Hagedorn, N; Sramkova, L; Mann, G; Panzer-Grümayer, R; Peters, C; Bourquin, J-P; Klingebiel, T; Borkhardt, A; Cario, G; Alten, J; Escherich, G; Astrahantseff, K; Seeger, K; Henze, G; von Stackelberg, A (2015). Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment. Leukemia, 29(8):1648-1655.

Tallen, G; Ratei, R; Mann, G; Kaspers, G; Niggli, F; Karachunsky, A; Ebell, W; Escherich, G; Schrappe, M; Klingebiel, T; Fengler, R; Henze, G; von Stackelberg, A (2010). Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90. Journal of Clinical Oncology, 28(14):2339-2347.

Möricke, A; Zimmermann, M; Reiter, A; Henze, G; Schrauder, A; Gadner, H; Ludwig, W D; Ritter, J; Harbott, J; Mann, G; Klingebiel, T; Zintl, F; Niemeyer, C; Kremens, B; Niggli, F; Niethammer, D; Welte, K; Stanulla, M; Odenwald, E; Riehm, H; Schrappe, M (2010). Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia, 24(2):265-284.

Conter, V; Bartram, C R; Valsecchi, M G; Schrauder, A; Panzer-Grümayer, R; Möricke, A; Aricò, M; Zimmermann, M; Mann, G; De Rossi, G; Stanulla, M; Locatelli, F; Basso, G; Niggli, F; Barisone, E; Henze, G; Ludwig, W D; Haas, O A; Cazzaniga, G; Koehler, R; Silvestri, D; Bradtke, J; Parasole, R; Beier, R; van Dongen, J J M; Biondi, A; Schrappe, M (2010). Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood, 115(16):3206-14.

Mauz-Körholz, C; Hasenclever, D; Dörffel, W; Ruschke, K; Pelz, T; Voigt, A; Stiefel, M; Winkler, M; Vilser, C; Dieckmann, K; Karlén, J; Bergsträsser, E; Fosså, A; Mann, G; Hummel, M; Klapper, W; Stein, H; Vordermark, D; Kluge, R; Körholz, D (2010). Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study. Journal of Clinical Oncology, 28(23):3680-3686.

Pichler, H; Möricke, A; Mann, G; Teigler-Schlegel, A; Niggli, F; Nebral, K; König, M; Inthal, A; Krehan, D; Dworzak, M N; Janousek, D; Harbott, J; Schrappe, M; Gadner, H; Strehl, S; Haas, O A; Panzer-Grümayer, R; Attarbaschi, A (2010). Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy. British Journal of Haematology, 149(1):93-100.

Bercovich, D; Ganmore, I; Scott, L M; Wainreb, G; Birger, Y; Elimelech, A; Shochat, C; Cazzaniga, G; Biondi, A; Basso, G; Cario, G; Schrappe, M; Stanulla, M; Strehl, S; Haas, O; Mann, G; Binder, V; Borkhardt, A; Kempski, H; Trka, J; Bielorei, B; Avigad, S; Stark, B; Smith, O; Dastugue, N; Bourquin, J-P; Tal, N B; Green, A R; Izraeli, S (2008). Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Lancet, 372(9648):1484-1492.

Möricke, A; Reiter, A; Zimmermann, M; Gadner, H; Stanulla, M; Dördelmann, N; Löning, L; Beier, R; Ludwig, W D; Ratei, R; Harbott, J; Boos, H; Mann, G; Niggli, F; Feldges, A; Henze, G; Welte, K; Beck, J D; Klingebiel, T; Niemeyer, C; Zintl, F; Bode, U; Urban, C; Wehinger, H; Niethammer, D; Riehm, H; Schrappe, M (2008). Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood, 111(9):4477-4489.

This list was generated on Thu Mar 21 10:28:37 2019 CET.